Compare CVS Health Corp (CVS) vs Johnson Controls International PLC (JCI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Johnson Controls International PLC — how do they compare? CVS Health Corp trades at $86.3 (market cap $112.49B), while Johnson Controls International PLC trades at $155.13 (market cap $94.45B). The key difference: CVS Health Corp is the larger of the two by market cap, and CVS Health Corp pays the higher dividend (3.02%). Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Johnson Controls International PLC for 65 Days on average.
| CVS | JCI | |
|---|---|---|
Market Cap | $112.49B | $94.45B |
Volume | 8,467,392 | 1,850,585 |
Sector | Health | Basic Materials |
52-Week High | $110.60 | $158.76 |
52-Week Low | $70.08 | $105.55 |
Typical Hold Time | 83 Days | 65 Days |
Enterprise Value | $174.83B | $103.29B |
Dividend Yield | 3.02% | 1.03% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.95, up 1.76% with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 26% upside. Recent quarterly earnings consistently beat expectations, with Q2 2026 EPS of $2.58 surpassing the $1.85 estimate. Revenue growth remains solid at $402.07 billion for 2025, though net margins compressed to 1.18%. Technical indicators show a bullish overall signal with support at $87 and resistance at $89.
The outlook remains positive given CVS's dominant market position and Medicare expansion plans, but investors face risks from reimbursement pressures and ongoing legal investigations. Earnings growth and successful execution of healthcare services integration represent the primary catalysts for continued stock appreciation.
JCI trades at $154.00, down 3.0% today, with a bullish technical outlook from moving averages but overbought RSI signals. The company reported strong Q2 2026 earnings, beating estimates with $1.42 EPS, and raised full-year guidance. Revenue for 2025 was $23.60B, with net income surging to $3.29B, driving a net margin of 13.94%. Analysts maintain a bullish consensus with a $172.50 price target, and recent news highlights institutional accumulation and positive coverage in AI industrial stocks.
JCI presents a favorable investment case supported by earnings momentum, robust profitability, and analyst optimism, though valuation multiples are elevated. Key risks include high debt levels, competitive pressures, and sensitivity to economic cycles. The stock's proximity to resistance at $157 suggests near-term consolidation potential, but fundamental strength supports long-term upside if execution continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Johnson Controls International PLC
Johnson Controls manufactures, installs, and services HVAC systems, building management systems and controls, industrial refrigeration systems, and fire and security solutions. Commercial HVAC accounts for about 40% of sales, fire and security also represents 40% of sales, and residential HVAC, industrial refrigeration, and other solutions account for the remaining 20% of revenue. In fiscal 2021, Johnson Controls generated over $23.5 billion in revenue.
Read more on JCI →
